Essential closer look at nanosized drug carriers 

Researchers have developed a protocol for studying how drug carrying nanoparticles called cubosomes behave in the body. The results show nanoparticle stability and confirm localisation in the cell. The study represents a significant step forward in the development of novel pharmaceuticals.

MAX IV and BESSY II initiate new collaboration to advance materials science

Swedish national synchrotron laboratory MAX IV and Helmholtz-Zentrum Berlin (HZB) BESSY II light source announce the signing of a 5-year cooperation agreement. The new agreement establishes a framework to strengthen cooperation for operational and technological development in the highlighted fields of accelerator research and development, beamlines and optics, endstations and sample environments as well as digitalisation and data science.

WISE beamline TomoWISE—a bright future with full-field tomography at MAX IV

MAX IV, Sweden’s national synchrotron laboratory welcomes TomoWISE, a full-field tomography beamline as the new chosen WISE beamline for the facility. The rigorous selection process was made possible thanks to relentless contributions by many actors. Selection of the new WISE beamline follows a three-year cooperation aimed at enabling new materials science for sustainability by the MAX IV organisation and the Wallenberg Initiative Materials Science for Sustainability (WISE) programme.

Research grants for structural biology at MicroMAX

User opportunities for studies of structural biology at the new X-ray crystallography beamline MicroMAX just got an upgrade. The Novo Nordisk Foundation is now offering funding for researchers affiliated with a Danish research institution to apply for grants for academic use of the beamline. The programme is called ‘MicroMAX Collaborative Research Grants.’

Inventive AI and robotic self-driving lab accelerates material discoveries

To find solutions to real-world challenges, researchers often need to do labour-intensive work that requires a time-consuming trial-and-error process. Developing a synthesis method for custom-made materials is one of them. The process can take years and is very hard to replicate. But what if technology could help solve this and accelerate the application of new functional materials? An international collaboration led by Andy Sode Anker from the Technical University of Denmark came to MAX IV and accomplished just that.

A path to polymerize metallic hydrogen?

An international research group reports in Nature the observation of the phase transition of a hexagonal close-packed (HCP) crystal structure of hydrogen to a 6-fold larger hydrogen supercell. The findings describe polymerization activity at extreme pressures which reveals how atoms arrange themselves in solid hydrogen and offers clues to the formation of metallic hydrogen. The study includes X-ray diffraction (XRD) data from MAX IV’s NanoMAX beamline.

The great planetary reset: Mapping glass pearls

Their days were numbered, all manner of Cretaceous life in kingdom plantae and animalia. Those that survived the impact winter became our modern groups of terrestrial and aquatic plants, animals, and marine plankton. Scientists want to understand how the Chicxulub asteroid that hit Earth 66 million years ago changed the conditions for life on the planet and veiled the sun for so many years, leading to the extinction of the dinosaurs. Secrets to this understanding are locked in the asteroid’s physical composition. An international research group has now produced a unique elemental map of the spherules formed by the asteroid impact, with data from MAX IV’s Balder and NanoMAX beamlines. The findings may better explain the aerosol cloud formation that catalysed extinction-level climate change.

High-resolution imaging provides clues to lung disease

Researchers have imaged lung tissue affected by Idiopathic Pulmonary Fibrosis (IPF) with nanometre resolution. They managed to capture differences in the distribution of trace elements compared to a healthy lung. The result is a step towards better understanding the body at the nanoscale and managing this and other currently untreatable diseases.